课题基金 / 基金详情

Assessment of Implementation Methods in Sepsis and Respiratory Failure

Assessment of Implementation Methods in Sepsis and Respiratory Failure
脓毒症和呼吸衰竭实施方法的评估
批准号:
10416329
负责人:
Mitchell M Levy
金额:
$75.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2027-06-30
关键词:
Academic DetailingAccident and Emergency departmentAcute respiratory failureAddressAdherenceAdmission activityAdoptionCaringCessation of lifeCharacteristicsClimateClinicalClinical DataClinical effectivenessCluster randomized trialCommunitiesCritical CareDataDatabasesEffectivenessElectronic Health RecordElementsEmergency Department patientEnrollmentEvaluationFutureGoalsGuidelinesHeterogeneityHospital MortalityHospitalsHourHybridsIncidenceInfectionIntensive Care UnitsInterventionInterviewLeadershipLearningLength of StayLinkLiquid substanceLungMeasuresMechanical ventilationMediatingMedicineMethodsModelingMulticenter TrialsNew YorkObservational StudyOutcomeOutcome MeasurePatient CarePatient-Focused OutcomesPatientsPerformancePhasePhenotypePopulation HeterogeneityPreparationPublishingRandomizedRandomized Clinical TrialsRelative RisksReportingResearchRespiratory DiseaseRespiratory FailureRespiratory Tract InfectionsResuscitationRisk ReductionScreening procedureSepsisSeptic ShockSocietiesSourceStructureSurveysTimeUnited StatesUnited States Centers for Medicare and Medicaid ServicesVentilatorWorkarmbaseclinical phenotypeclinical practicecohortcomparative effectivenesscompare effectivenesseffectiveness evaluationeffectiveness implementation studyeffectiveness implementation trialeffectiveness outcomeevidence baseexperienceimplementation facilitationimplementation facilitatorsimplementation frameworkimplementation interventionimplementation processimplementation scienceimplementation strategyimprovedimproved outcomeindividualized medicinemeetingsmortalitynovelorganizational readinesspragmatic trialprecision medicineprimary outcomeprogramsrandomized trialrespiratoryresponsesecondary outcomeseptic patientsstandard of caresustainability frameworktreatment effectuptake

项目摘要

项目成果

Mitchell M Levy的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Sepsis is the leading cause of admission to intensive care units (ICUs) in the U.S., and the leading cause of respiratory failure and death in ICUs. The majority of ICU patients with sepsis or septic shock have either respiratory infection as the source of sepsis, or have respiratory failure requiring mechanical ventilation. In recognition of the burden of sepsis in the U.S., sepsis “bundles” were introduced to facilitate guideline implementation in clinical practice (known as the 3-Hour bundle). Since the introduction of sepsis bundles, multiple observational studies have demonstrated a consistent, strong association between implementation of sepsis bundles and improved survival. These data led to the New York State (NYS) Sepsis initiative, which demonstrated a significant association between adherence with sepsis bundles and improved survival, and the Centers for Medicare and Medicaid Services (CMS) mandated public reporting of sepsis measures (SEP-1). Analysis of the NYS database has revealed that completion of the 3-Hour bundle in patients with respiratory failure was associated with an 8.6% absolute reduction in mortality (18.5 RRR). For those patients who completed the 3-Hour bundle within 1 hour, the mortality reduction was even higher, 9.8% (RRR 21.7%). In 2018, the Hour-1 bundle was published to underscore the need for urgency in the treatment of septic patients. We believe that the primary beneficial effect of both the Hour-1 and 3-Hour bundle is in patients with respiratory failure. It is not known if implementation of the Hour-1 bundle reduces mortality more than the 3 Hour bundle. Although adherence with the 3-Hour bundle (SEP-1) is mandated by CMS, compliance is moderate (60%), suggesting an active implementation process for the 3-hour bundle is necessary to compare the Hour-1 bundle to the 3-Hour bundle. The current proposal is a pragmatic, cluster-randomized clinical trial using a hybrid type 2 effectiveness-implementation approach to evaluate mortality and respiratory failure-based outcomes and bundle adherence, in emergency room patients with sepsis. We will compare the hour-1 bundle to the 3-hour bundle. The outcome measures include hospital mortality, hospital length of stay, ventilator-free days, and incidence of respiratory failure. The effectiveness of a clinical intervention (Hour-1 bundle) is implemented using a rigorous implementation strategy (the Exploration, adoption/Preparation, Implementation, Sustainment – EPIS – multi-level conceptual model) for both the 1- and 3-Hour bundles. We will also evaluate a possible precision-based approach in this study. Routine clinical information available at hospital presentation will identify 4 discrete, sepsis phenotypes and we hypothesize that 2 of these identify patients who are significantly more likely to benefit from the 1-Hour bundle in future studies. Our team has extensive experience conducting multi-center trials in sepsis guided by effective models of implementation science. We have developed automated screening tools to identify patients with sepsis and have guided state-wide implementation of sepsis performance measures. We have also used automated EHR methods to screen for and enroll septic patients into these studies. This novel, hybrid type 2 effectiveness-implementation approach addresses key gaps to facilitate the implementation of evidence-based strategies to improve patient outcomes from sepsis and acute respiratory failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessment of Implementation Methods in Sepsis and Respiratory Failure
  • 批准号:
    10665714
  • 项目类别:
  • 资助金额:
    $72.26万
  • 财政年份:
    2022
  • 负责人:
    Mitchell M Levy
  • 依托单位: